Skip to main content

Table 2 Background regimens used in combination with bedaquiline

From: Bedaquiline-containing regimens in patients with pulmonary multidrug-resistant tuberculosis in China: focus on the safety

Drug Patients (n = 1162), n (%)
Linezolid 1030 (88.6)
Cycloserine 962 (82.8)
Clofazimine 694 (59.7)
Protionamide 592 (50.9)
Amikacin 482 (41.5)
Moxifloxacin 467 (40.2)
Aminosalicylic acid 399 (34.3)
Pyrazinamide 293 (25.2)
Capreomycin 214 (18.4)
Levofloxacin 157 (13.5)
Ethambutol 132 (11.4)
Amoxicillin; clavulanate potassium 61 (5.2)
Pasiniazid 17 (1.5)
Isoniazid 14 (1.2)
Clarithromycin 8 (0.7)
Cilastatin; imipenem 1 (0.1)
Gatifloxacin 1 (0.1)
Meropenem 1 (0.1)
Rifabutin 1 (0.1)
Streptomycin 1 (0.1)
Terizidone 1 (0.1)